Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications
The age-related decline of serum T occurs in ~20–30% of adult men and it is today defined as late-onset hypogonadism (LOH). In the elderly, such decline becomes more prevalent (up to 60%) and shows-up with erectile dysfunction (ED) and hypoactive sexual desire. A large body of experimental evidences...
Main Authors: | Antonio Aversa, Ylenia Duca, Rosita Angela Condorelli, Aldo Eugenio Calogero, Sandro La Vignera |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00225/full |
Similar Items
-
Evolution of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction in Taiwan
by: Bang-Ping Jiann
Published: (2016-06-01) -
Adherence to Phosphodiesterase Type 5 Inhibitors in the Treatment of Erectile Dysfunction in Long-Term Users: How Do Men Use the Inhibitors?
by: Ana Carvalheira, PhD, et al.
Published: (2014-06-01) -
Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: No. Ten reasons that there will be no new pharmacologic therapies for erectile dysfunctionin the foreseeable future
by: Ira D. Sharlip
Published: (2015-10-01) -
Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: Yes
by: Stanley E. Althof
Published: (2015-10-01) -
Is There an Association Between Vitamin D Deficiency and Erectile Dysfunction? A Systematic Review and Meta-Analysis
by: Andrea Crafa, et al.
Published: (2020-05-01)